English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18259/20457 (89%)
造訪人次 : 6272529      線上人數 : 564
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34937


    標題: Transpulmonary Expression of Exosomal microRNAs in Idiopathic and Congenital Heart Disease-Related Pulmonary Arterial Hypertension
    作者: Chang, Wei-Ting
    Lee, Wei-Chieh
    Lin, Yu-Wen
    Shih, Jhih-Yuan
    Hong, Chon-Seng
    Chen, Zhih-Cherng
    Chu, Chun-Yuan
    Hsu, Chih-Hsin
    貢獻者: Natl Sun Yat sen Univ, Coll Med, Sch Med, Doctoral Program Clin & Expt Med
    Natl Sun Yat sen Univ, Ctr Excellence Metab Associated Fatty Liver Dis
    Chi Mei Med Ctr, Dept Internal Med, Div Cardiol
    Natl Sun Yat sen Univ, Coll Med, Sch Med
    Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr
    Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol
    Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med
    Natl Cheng Kung Univ Hosp
    關鍵字: congenital heart disease
    exosome microRNAs
    pulmonary artery hypertension
    transpulmonary expression
    日期: 2023
    上傳時間: 2024-12-25 11:05:56 (UTC+8)
    出版者: WILEY
    摘要: Background: Pulmonary artery hypertension (PAH) is a fatal disease characterized by a complex pathogenesis. Exosomes containing microRNAs (miRs) have emerged as a novel biomarker. Transpulmonary exosomal miRs offer valuable insights into pulmonary circulation microenvironments. Hereby, we aimed to explore the potentials of transpulmonary exosomal miRs as differentiating factors between idiopathic PAH and congenital heart disease (CHD)-related PAH.Methods and Results: During right heart catheterization, we collected exosomes at pulmonary arteries in 25 patients diagnosed with idiopathic PAH and 20 patients with CHD-related PAH. Next-generation sequencing identified several candidate exosomal miRs. Using quantitative polymerase chain reaction, we validated the expressions of these miRs and revealed significantly elevated expressions of miR-21, miR-139-5p, miR-155-5p, let-7f-5p, miR-328-3p, miR-330-3p, and miR-103a-3p in patients with CHD-related PAH, in contrast to patients with idiopathic PAH. Among these miRs, miR-21 exhibited the highest expression in patients with CHD-related PAH. These findings were further corroborated in an external cohort comprising 10 patients with idiopathic PAH and 8 patients with CHD-related PAH. Using an in vitro flow model simulating the shear stress experienced by pulmonary endothelial cells, we observed a significant upregulation of miR-21. Suppressing miR-21 rescued the shear stress-induced downregulation of the RAS/phosphatidylinositol 3-kinase/protein kinase B pathway, leading to a mitigation of apoptosis.Conclusions: Our study identified a pronounced expression of transpulmonary exosomal miR-21, particularly in patients with CHD-related PAH, through next-generation sequencing analysis. Further investigation is warranted to elucidate the regulatory mechanisms involving miR-21 in the pathophysiology of PAH.
    關聯: Journal of The American Heart Association, v.12, n.23
    顯示於類別:[保健營養系(所) ] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML65檢視/開啟
    JAHA.123.031435.pdf7755KbAdobe PDF77檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋